IN THE HALLS OF CONGRESS, A GOOD NEWS/BAD NEWS STORY is unfolding around the multi-year cuts to the prices Medicare pays for clinical laboratory tests. First the good news. In its latest semi-annual report to Congress, the Medicare Payment Advisory Commission (MedPAC) confirms much of what the clinical laboratory industry has been saying about Medicare’s new lab test payment […]
- Regulatory Update
MedPAC Reports to Congress on Issues in Lab Test Price Survey
Yes, CMS’ collection of private payer lab price data fails to collect prices paid to hospital labs, POLs
- By Robert Michel
- > From the Volume XXVIII, No. 13 - September 27, 2021 Issue
- Tags: acla, American Clinical Laboratory Association, Centers for Medicare and Medicaid Services, clfs, CMS, Julie Khani, lab risk & compliance, Mark Birenbaum PhD, medicare clinical laboratory fee schedule, Medicare Payment Advisory Commission, MedPAC, national independent laboratory association, NILA, PAMA, physician office laboratory, POL, Protecting Access to Medicare Act
